Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis... Read more
Silverback is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of cancer and fibrosis... Read more
2016
PublicMerged with ARS Pharmaceuticals, Inc.NASDAQSBTX
News
Nov 22, 2022
24/7 Wall St.
Silverback Therapeutics: ARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger
Nov 08, 2022
MarketScreener
Silverback Therapeutics: ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
Aug 10, 2022
PR Newswire
Press Release: Silverback Therapeutics : SILVERBACK THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Silverback Therapeutics, Inc. - SBTX
Jul 27, 2022
Global Legal Chronicle
Silverback Therapeutics: Silverback Therapeutics' Merger With ARS Pharmaceuticals
May 17, 2022
MarketScreener
Silverback Therapeutics: Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
May 13, 2022
FirstWord Pharma
Silverback Therapeutics: Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Apr 01, 2022
PharmaLive
Silverback Therapeutics: Silverback Halts Oncology Programs, Lays Off 27% Of Staff
Apr 01, 2022
Business Wire
Press Release: Silverback Therapeutics : Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 24, 2022
Business Wire
Press Release: Silverback Therapeutics : Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference
Feb 17, 2022
The seattle Times
Silverback Therapeutics: Shareholders accuse Seattle health startup of 'misleading investors' after IPO
Silverback Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10